Picture BIO Deutschland Corona Special Germany 2020 650x80px
Organisation › Details

Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY)

Epigenomics AG is a molecular diagnostics company with a focus on the development of novel products for cancer. Using DNA methylation biomarkers, Epigenomics' tests on the market and in development for colorectal, lung, and prostate cancer aim at aiding in an earlier and more accurate diagnosis of these diseases, thereby potentially increasing the patient's chances of survival. For development and global commercialization of IVD test products, Epigenomics pursues a dual business strategy in which direct commercialization of proprietary diagnostic test products is combined with non-exclusive licensing to diagnostic industry players with broad customer access. Strategic diagnostics industry partners include Abbott Molecular, Sysmex Corporation, Quest Diagnostics Incorporated, ARUP Laboratories, Inc., and Warnex Laboratories, Inc. for diagnostics test products and services, and QIAGEN N.V. for sample preparation solutions and research products. The company is headquartered in Berlin, Germany, and has a wholly owned subsidiary, Epigenomics Inc., in Seattle, WA, USA. *


Period Start 1998-01-01 established
  Group Epigenomics (Group)
  Predecessor Epigenomics GmbH
Products Industry molecular diagnostics
  Industry 2 pharmacogenomics/pharmacogenetics
Persons Person Hamilton, Gregory (Greg) (Epigenomics 201607– CEO before AltheaDx + Enigma Diagnostics + Third Wave + Hologic)
  Person 2 Staub, Uwe (Epigenomics 201210– promoted COO before SVP R&D before Qiagen before Digene before Abbott Diagnostics)
Region Region Berlin
  Country Germany
  Street 5 Geneststr.
  City 10829 Berlin
  Tel +49-30-24345-0
    Address record changed: 2018-07-24
Basic data Employees B: 11 to 50 (2017-12-31)
  Currency EUR
  Annual sales 4,201,000 (revenue, consolidated (2016) 2016-12-31)
  Profit -10,235,000 (2017-12-31)
  Cash 12,826,000 (2017-12-31)
    * Document for �About Section�: Epigenomics AG. (1/13/10). "Press Release: Epigenomics Provides Update on Progress with US Product Development for Epi proColon". Berlin & Seattle, WA.
Record changed: 2020-01-01


Picture [LSE] – The Business Web Portal 650x65px

More documents for Epigenomics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

» top